npj Primary Care Respiratory Medicine (Jan 2017)

Development and validation of the Salzburg COPD-screening questionnaire (SCSQ): a questionnaire development and validation study

  • Gertraud Weiss,
  • Ina Steinacher,
  • Bernd Lamprecht,
  • Bernhard Kaiser,
  • Romana Mikes,
  • Lea Sator,
  • Sylvia Hartl,
  • Helga Wagner,
  • M. Studnicka

DOI
https://doi.org/10.1038/s41533-016-0005-7
Journal volume & issue
Vol. 27, no. 1
pp. 1 – 8

Abstract

Read online

Chronic obstructive pulmonary disease: Questionnaire for pre-screening potential sufferers Scientists in Austria have developed a brief, simple questionnaire to identify patients likely to have early-stage chronic lung disease. Chronic obstructive pulmonary disease (COPD) is notoriously difficult to diagnose, and the condition often causes irreversible lung damage before it is identified. Finding a simple, cost-effective method of pre-screening patients with suspected early-stage COPD could potentially improve treatment responses and limit the burden of extensive lung function (‘spirometry’) tests on health services. Gertraud Weiss at Paracelsus Medical University, Austria, and co-workers have developed and validated an easy-to-use, self-administered questionnaire that could prove effective for pre-screening patients. The team trialed the five-point Salzburg COPD-screening questionnaire on 1258 patients. Patients scoring 2 points or above on the questionnaire underwent spirometry tests. The questionnaire seems to provide a sensitive and cost-effective way of pre-selecting patients for spirometry referral.